Canterbury DHB
|
|
Dr Kate Grundy FRACP FAChPM Clinical Director Palliative Care Anne Morgan SRN, DipN (Lond), MA (Applied) Palliative Care Nurse Consultant |
We wish to thank Ruth Tramschek, Oncology Pharmacist, Christchurch Hospital for her assistance in the preparation of this publication. Click here to open an Acrobat (PDF) version of these guidelines, suitable for printing. |
DISCLAIMER Every effort has been made to ensure the accuracy of this text, and that the best information available has been used. This does not diminish the requirement to exercise clinical judgement, and neither the publishers nor the authors can accept responsibility for its use in practice. Some medications are used for indications, by routes or in doses that are not approved by New Zealand licensing. This is common practice and validated internationally. For more information see |
|
First written March 2001 |
|
Have you read the |
|
Topic Code: 4207